Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging

Autor: Sandra Mounicou, Pierre-Arnaud Faye, Olivia Sgarbura, Lucie Rebel, Marion Larroque, Cristina Leaha, Carine Arnaudguilhem, Brice Bouyssiere, Sébastien Carrere, Christine Enjalbal, François Quénet

Publikováno v: Pleura and Peritoneum
Pleura and peritoneum
Pleura and peritoneum, Walter de Gruyter GmbH, 2021, 24 (6(2)), pp.:67-74. ⟨10.1515/pp-2020-0149⟩
Pleura and peritoneum, 2021, 24 (6(2)), pp.:67-74. ⟨10.1515/pp-2020-0149⟩

Objectives Platinum salts are commonly used in hyperthermic intraperitoneal chemotherapy (HIPEC) for digestive tract cancer treatment. During HIPEC with oxaliplatin for peritoneal metastases (PMs) treatment, the ovaries are directly exposed to the dr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c4ca244cd58a6f7428571afa94b366
https://pubmed.ncbi.nlm.nih.gov/34179340